Wave Life Sciences Ltd.

NASDAQ:WVE

8.34

+0.33 (+4.12%)

5:25:33 PM EDT: $8.30 -0.04 (-0.48%)

Market Cap (Intraday)	1.35B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$14.31 Million
Adjusted EPS	-$0.27

See more estimates

10-Day MA	$7.73
50-Day MA	$6.82
200-Day MA	$10.13

See more pivots

Wave Life Sciences Ltd. Stock, NASDAQ:WVE

Marina One East Tower, 7 Straits View, Singapore, Central Singapore 018936

Singapore

Phone: +65.6236.3388

Number of Employees: 288

http://www.wavelifesciences.com

Description

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.